GlassScriptPhysician profile
Jennifer M Vivio
NPI 1447254008
$19,755.42
in general payments reported to CMS, 2019-2025
69 companies · $4,578 in 2025
The $4,578 reported for 2025 was more than what 84% of Neurology (Psychiatry & Neurology) providers received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,809 · 2020: $1,558 · 2021: $2,551 · 2022: $2,572 · 2023: $3,046 · 2024: $3,641 · 2025: $4,578.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $11K · Education: $64.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $11,200.26 |
| Education | $64.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,251.81 | 2019-2025 | Qulipta, Botox, Ubrelvy |
| Novartis Pharmaceuticals Corporation | $1,414.29 | 2019-2025 | |
| Ucb, INC. | $1,157.36 | 2019-2025 | Briviact, Rystiggo, Nayzilam |
| Biogen, INC. | $1,078.02 | 2019-2025 | Vumerity, Tysabri, Avonex |
| Mdd US Operations, LLC | $902.46 | 2019-2025 | Apokyn, Apokyn |
| Jazz Pharmaceuticals INC. | $739.79 | 2019-2025 | |
| Eisai INC. | $690.38 | 2019-2025 | |
| Amgen INC. | $586.10 | 2019-2025 | Uplizna, Aimovig |
| Genzyme Corporation | $529.70 | 2019-2025 | |
| Vanda Pharmaceuticals INC. | $529.27 | 2021-2025 | Ponvory, Fanapt, Hetlioz |
| Pfizer INC. | $524.97 | 2019-2025 | |
| Catalyst Pharmaceuticals, INC. | $513.69 | 2022-2025 | Fycompa, Firdapse |
| Harmony Biosciences LLC | $512.94 | 2020-2025 | Wakix |
| Neurocrine Biosciences, INC. | $509.01 | 2019-2025 | Ingrezza, Ongentys |
| Sk Life Science, INC. | $454.74 | 2021-2025 |
Show all 69 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $439.64 | 2020-2025 | Kisunla, Amyvid, Emgality |
| Supernus Pharmaceuticals, INC. | $424.87 | 2019-2022 | |
| Lundbeck LLC | $396.19 | 2019-2025 | Vyepti |
| Allergan, INC. | $389.30 | 2019-2022 | |
| Genentech USA, INC. | $355.43 | 2019-2025 | Ocrevus, Ocrevus Zunovo |
| Alnylam Pharmaceuticals INC. | $339.40 | 2020-2025 | Onpattro, Amvuttra |
| Emd Serono, INC. | $316.88 | 2019-2023 | Mavenclad |
| Alexion Pharmaceuticals, INC. | $316.47 | 2019-2025 | Ultomiris, Soliris |
| Amneal Pharmaceuticals LLC | $292.04 | 2019-2025 | Rytary, Crexont |
| Teva Pharmaceuticals USA, INC. | $259.10 | 2020-2025 | Austedo Xr, Austedo Xr |
| Livanova USA, INC. | $235.19 | 2019-2024 | Vns Therapy Sentiva Model 1000 Generator |
| Janssen Pharmaceuticals, INC | $235.10 | 2020-2024 | Spravato, Ponvory |
| Celgene Corporation | $220.59 | 2022-2025 | Zeposia |
| Argenx US, INC. | $199.26 | 2023-2025 | Vyvgart, Vyvgart Hytrulo |
| Acadia Pharmaceuticals INC | $186.96 | 2019-2025 | Nuplazid, Daybue |
| Banner Life Sciences, LLC | $173.99 | 2022-2024 | |
| Biohaven Pharmaceutical Holding Company LTD. | $151.98 | 2022 | |
| Sunovion Pharmaceuticals INC. | $147.22 | 2021-2022 | |
| Tanabe Pharma America, INC. | $144.04 | 2021-2025 | Radicava |
| Sumitomo Pharma America, INC. | $141.92 | 2023-2024 | Aptiom, Brovana |
| Neurelis, INC. | $131.81 | 2020-2025 | Valtoco |
| Csl Behring | $131.40 | 2021-2025 | Hizentra |
| Tg Therapeutics, INC. | $121.83 | 2023-2025 | |
| Springworks Therapeutics, INC. | $118.00 | 2025 | Gomekli |
| Horizon Therapeutics Plc | $115.19 | 2022-2023 | Uplizna |
| Grifols USA, LLC | $112.15 | 2023-2025 | Gamunex-C |
| Kyowa Kirin, INC. | $94.16 | 2019-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $85.41 | 2024-2025 | Hyqvia |
| Arbor Pharmaceuticals, INC. | $83.11 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $80.93 | 2020-2022 | |
| Scilex Pharmaceuticals INC. | $80.26 | 2024 | |
| Avanir Pharmaceuticals, INC. | $75.04 | 2019-2022 | |
| Mallinckrodt Hospital Products INC. | $68.84 | 2022 | |
| Biohaven Pharmaceuticals, INC. | $67.66 | 2021 | |
| Greenwich Biosciences, INC. | $51.81 | 2019-2021 | |
| Aucta Pharmaceuticals, INC. | $51.01 | 2025 | Motpoly Xr |
| Aprecia Pharmaceuticals, LLC | $46.51 | 2019-2020 | |
| Otsuka America Pharmaceutical, INC. | $45.56 | 2025 | Rexulti |
| Impel Pharmaceuticals INC. | $42.68 | 2023 | Trudhesa |
| Avion Pharmaceuticals | $41.28 | 2022-2023 | Dhivy |
| Inspire Medical Systems, INC. | $36.74 | 2025 | Inspire |
| Acorda Therapeutics, INC | $36.28 | 2021-2022 | |
| Adamas Pharmaceuticals, INC. | $34.29 | 2019 | |
| Chiesi USA, INC. | $30.91 | 2024 | Cleviprex |
| Idorsia Pharmaceuticals US INC | $30.70 | 2023 | Quviviq |
| Cycle Pharmaceuticals INC | $28.57 | 2025 | Bafiertam |
| Axsome Therapeutics, INC. | $25.82 | 2023 | Sunosi |
| Azurity Pharmaceuticals, INC. | $24.34 | 2025 | Horizant |
| Boston Scientific Corporation | $22.98 | 2019 | |
| Vertical Pharmaceuticals, LLC | $19.94 | 2019 | |
| Saol Therapeutics INC. | $16.36 | 2019 | |
| Braemar Manufacturing, LLC | $15.66 | 2019 | |
| Almatica Pharma LLC | $14.69 | 2021 | |
| Zyla Life Sciences, INC. | $13.40 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jennifer Vivio listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.